Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions

E-ISSN： 1873-5576|16|8|710-720

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.16, Iss.8, 2016-10, pp. : 710-720

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapy of Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia

Current Pharmaceutical Design, Vol. 18, Iss. 23, 2012-08 ,pp. : 3399-3405

Bentham Science Publishers

Access to resources Recommend Favorite

Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge

Current Cancer Drug Targets, Vol. 16, Iss. 8, 2016-09 ,pp. : 701-709

Bentham Science Publishers

Access to resources Recommend Favorite

Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemia

By Balakrishnan Kumudha Gandhi Varsha

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 4, 2012-04 ,pp. : 409-423

Informa Healthcare

Access to resources Recommend Favorite

Pentostatin in chronic lymphocytic leukemia

By Sauter Craig Lamanna Nicole Weiss Mark A

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 9, 2008-09 ,pp. : 1217-1222

Informa Healthcare

Access to resources Recommend Favorite

FCR and bevacizumab treatment in patients with relapsed chronic lymphocytic leukemia

Cancer, Vol. 120, Iss. 22, 2014-11 ,pp. : 3494-3501

Blackwell Publishing

Access to resources Recommend Favorite